In this CE activity, experts in the field review the latest clinical findings and real-world evidence regarding the use of currently available medical advances for the treatment of patients with nAMD, DME, and RVO, and evaluate the latest clinical data on emerging treatment options for the medical management of these patients.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://cme.healio.com/retinacme/age-related-macular-degeneration/20240223/rapid-response-from-angiogenesis-2024/overview
- Start Date: 2024-02-23 06:00:00
- End Date: 2024-02-23 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Genentech, a member of the Roche Group - Amount: 64468.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest